# Study to Evaluate the Immune Response of United Kingdom (UK) Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Life

> **NCT00625677** · PHASE4 · COMPLETED · sponsor: **Public Health England** · enrollment: 130 (estimated)

## Conditions studied

- Meningococcal Infections
- Pneumococcal Infections

## Interventions

- **BIOLOGICAL:** NeisVacC (Meningococcal C conjugate vaccine)
- **BIOLOGICAL:** Menjugate (Meningococcal C conjugate vaccine)

## Key facts

- **NCT ID:** NCT00625677
- **Lead sponsor:** Public Health England
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2019-03-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00625677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00625677, "Study to Evaluate the Immune Response of United Kingdom (UK) Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Life". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00625677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*